About: A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) (en)
skos:prefLabel	A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) (en)
name	A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) (en)
title	wds:Q64139476-7C4FBFBF-9466-4FF4-AE9F-86E88737D4C1
title	A Phase II Multi-Center, Randomized, Double-Blind, 24-Week, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Children and Adolescents Age 5-17 With Autism Spectrum Disorder (ASD) (en)
end time	wds:Q64139476-EE6A0693-ABA5-4BD1-9276-CEE91E58E2B6
end time	2021-07-06 00:00:00Z (xsd:dateTime)
instance of	wds:Q64139476-75E9915F-DF83-4583-8825-14463581CEE1
instance of	clinical trial
start time	wds:Q64139476-8EC0D368-B722-4C78-871C-E55F7484BE79
start time	2016-11-21 00:00:00Z (xsd:dateTime)
country	wds:Q64139476-9B0BAD56-DA45-474D-BE61-3ADDA236CC8B
country	United States of America
research site	wds:Q64139476-13931EB3-DC21-4BB5-8323-022BDBB252A7 wds:Q64139476-163BE563-3FBF-47A3-BB5C-38BE0377F8D3 wds:Q64139476-170D6B6E-CD7B-4F2E-AD67-C9DE22D81457 wds:Q64139476-28E8A53D-AB31-449A-8C9D-258021D853AA wds:Q64139476-B41D1C7F-7F52-419F-A31A-CFBBA6C1E0A9 wds:Q64139476-C2208E15-EF10-40F3-92F5-3A9059CEE190 wds:Q64139476-D6255323-AECD-44A2-AECB-6BD502AEE811 wds:Q64139476-DED607B7-EC7E-4989-BDC2-D369B5A73F63 wds:Q64139476-FE56885E-3CD0-4CF8-B443-ED1320EF000A
research site	University of Massachusetts University of Rochester University of California, San Francisco Massachusetts General Hospital Rush University Medical Center Vanderbilt University Medical Center Cincinnati Children's Hospital Medical Center Ohio State University Northwest Clinical Research Center
minimum age	wds:Q64139476-0C26C314-587F-4DBE-A50C-B4B8CC3FC70B
minimum age	5 (xsd:decimal)
medical condition	wds:Q64139476-9D5EFEB9-D7BA-4A36-BAC5-90093BFB9A9D
sponsor	wds:Q64139476-9C39482D-BAD0-4D4F-B73F-8A81F2CEA9EB
medical condition	autism spectrum disorder
sponsor	Chemische Werke Grenzach
number of participants	wds:Q64139476-670FA175-EFC0-4A6F-AC48-0892986EF9E8
number of participants	340 (xsd:decimal)
maximum age	wds:Q64139476-38A146DE-0EB6-4DFD-99A9-B821E253DD3C
maximum age	17 (xsd:decimal)
study type	wds:Q64139476-8ED8DB95-646D-40FF-9377-8B4CF741FB58
study type	interventional study
ClinicalTrials.gov ID	wds:Q64139476-4DEDF915-53C9-4D9D-ADEA-BA545C603681
ClinicalTrials.gov ID	NCT02901431
clinical trial phase	wds:Q64139476-F648B375-A060-484C-97B2-42976EBE71E7
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64139476

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software